2019
DOI: 10.1016/j.jim.2018.11.014
|View full text |Cite
|
Sign up to set email alerts
|

Cross-species reactive monoclonal antibodies against the extracellular domains of the insulin receptor and IGF1 receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
3

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 23 publications
0
5
0
Order By: Relevance
“…Our scoring method is well suited for this task, as we demonstrated scoring of antibody variants for both antigen and non-specific binding and showed that these scores were predictive of co-optimal variants along the experimental Pareto frontier. This method could be expanded to select antibodies with various co-optimal sets of properties, including broadly neutralizing variants against multiple viruses ( Sok and Burton 2018 , Magar et al 2021 ) or species cross-reactive antibodies against orthologs of the same target for clinical translation ( Ørstrup et al 2019 , Li et al 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…Our scoring method is well suited for this task, as we demonstrated scoring of antibody variants for both antigen and non-specific binding and showed that these scores were predictive of co-optimal variants along the experimental Pareto frontier. This method could be expanded to select antibodies with various co-optimal sets of properties, including broadly neutralizing variants against multiple viruses ( Sok and Burton 2018 , Magar et al 2021 ) or species cross-reactive antibodies against orthologs of the same target for clinical translation ( Ørstrup et al 2019 , Li et al 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…To explore the molecular mechanisms associated with INSR internalization, we conducted co-immunoprecipitation followed by mass-spectrometry to identify INSR interactors. We also used INSR knockout C2C12 myoblasts as an negative control and an INSR antibody that does not cross-react with Insulin-like growth factor 1 receptor (IGF1R) 23 to identify INSR interactors with higher specificity than any previously reported study. After filtering the detected proteins against the INSR knockout cell control lysates, we identified INSR and five high-confidence INSR-binding proteins (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…C2C12 myoblasts were serum-starved for 6 hours and were given 0 or 2 nM insulin for 15 min before collecting their lysates in RIPA buffer. INSRα antibody (NNC0276-3000, a gift from NovoNordisk compound sharing program) that does not cross-react with IGF1R 23 was covalently conjugated to Dynabeads M-270 Epoxy beads (Cat. #14301, Invitrogen) to immunoprecipitate INSR according to the manufacture’s protocol.…”
Section: Methodsmentioning
confidence: 99%
“…Our scoring method is well suited for this task, as we demonstrated scoring of antibody variants for both antigen and non-specific binding and showed that these scores were predictive of co-optimal variants along the experimental Pareto frontier. This method could be expanded to select antibodies with various co-optimal sets of properties, including broadly neutralizing variants against multiple viruses (Sok et al 2018;Magar et al 2021) or species cross-reactive antibodies against orthologs of the same target for clinical translation (Ørstrup et al 2019;Li et al 2020).…”
Section: Discussionmentioning
confidence: 99%